Literature DB >> 6796717

Trace metal abnormalities in adults during hyperalimentation.

C J McClain.   

Abstract

Trace metal deficiencies are now a well-documented complication of total parenteral nutrition (TPN). Zinc deficiency may present in a variety of ways including acrodermatitis skin lesions, impaired immunity, poor growth or impaired wound healing, and mental disturbances. Copper deficiency presents a more uniform picture of hematologic abnormalities, usually anemia with leukopenia and neutropenia. Chromium and selenium deficiencies occur much less frequently, but well-documented cases have been reported. We currently recommended regular monitoring and supplementation of these four trace metals during TPN administration. This article describes the clinical abnormalities that may develop when deficiencies of trace metals occur during TPN administration, and we present recommendations for trace metal supplementation during TPN administration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796717     DOI: 10.1177/0148607181005005424

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

Review 1.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

2.  Urinary excretion and blood concentrations of trace elements and electrolytes during total parenteral nutrition in Crohn's disease.

Authors:  S Jacobson; L O Plantin; B Carlmark
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

3.  Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case series.

Authors:  Deborah A Pasko; Mariann D Churchwell; Imad F Btaiche; Jinesh C Jain; Bruce A Mueller
Journal:  Pediatr Nephrol       Date:  2009-01-21       Impact factor: 3.714

4.  Ocular histopathology of acrodermatitis enteropathica.

Authors:  J D Cameron; C J McClain
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.